Bioelectronics Corp (BIEL)

[uksausage]

expecting a doubling of revenues by years end with Braun (large order in Q3) and Canada coming on line

Also do expect the FDA decision to be out by years end

So would expect the pps to be much higher by then which was my original point

Whether the company is technically in cash flow positive by then is moot. I guess it will take more than doubling but I'm not sure what their margins with Braun will be, it is for recoveryRx and if claimable on insurance that usually allows for lots of margins for all concerned. (certainly higher than actipatch through Boots)